Elicio Therapeutics Inc — Quarterly Cash Flow (NASDAQ:ELTX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 28.18 M28.14 M29.53 M28.28 M25.86 M Total liabilities 39.49 M19.24 M27.69 M24.47 M24.23 M Total equity -11.31 M8.9 M1.83 M3.82 M1.64 M Total liabilities & shareholders' equities 28.18 M28.14 M29.53 M28.28 M25.86 M Total debt 20.03 M09.34 M9.72 M9.41 M Net debt 2.42 M-18.35 M-12.75 M-10.89 M-9.16 M

Haberler

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Elicio Therapeutics 100 milyon dolarlık hisse arzı başlattı

H.C. Wainwright, Elicio Therapeutics için hedef fiyatı 17 dolara yükseltti

H.C. Wainwright raises Elicio Therapeutics price target to $17

Rodman & Renshaw, Elicio Therapeutics hissesi için al önerisi verdi

Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating

Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why

Elicio, değerlendirilen kanser hastalarının %87’sinde antijen yayılımı bildiriyor

Elicio reports antigen spreading in 87% of evaluated cancer patients

Elicio Therapeutics, Marc Wolfgang’u teknoloji direktörü olarak atadı

Elicio Therapeutics appoints Marc Wolfgang as chief technology officer